891 related articles for article (PubMed ID: 19004698)
1. Counterfeiting and piracy of pharmaceuticals.
Grackin A
IEEE Eng Med Biol Mag; 2008; 27(6):66-9. PubMed ID: 19004698
[No Abstract] [Full Text] [Related]
2. New countermeasures considered as drug counterfeiting grows.
Schubert C
Nat Med; 2008 Jul; 14(7):700. PubMed ID: 18607355
[No Abstract] [Full Text] [Related]
3. Promoting public health and protecting consumers in a global economy: an overview of HHS/FDA's international activities.
Kelly DP; Bachorik LL
Food Drug Law J; 2005; 60(3):339-46. PubMed ID: 16304741
[No Abstract] [Full Text] [Related]
4. The importance and challenges of "mutual recognition".
Merrill RA
Seton Hall Law Rev; 1998; 29(2):736-55. PubMed ID: 10569829
[No Abstract] [Full Text] [Related]
5. Deterring the importation of counterfeit pharmaceutical products.
Stearn DW
Food Drug Law J; 2004; 59(4):537-61. PubMed ID: 15875351
[No Abstract] [Full Text] [Related]
6. Pharmaceutical counterfeiting.
Deisingh AK
Analyst; 2005 Mar; 130(3):271-9. PubMed ID: 15724152
[TBL] [Abstract][Full Text] [Related]
7. [Update on counterfeit drugs: a growing risk for public health].
Juillet Y
Bull Acad Natl Med; 2008 Oct; 192(7):1423-34; discussion 1434-6. PubMed ID: 19445366
[TBL] [Abstract][Full Text] [Related]
8. Counterfeit drugs: implications for health.
ten Ham M
Adverse Drug React Toxicol Rev; 1992; 11(1):59-65. PubMed ID: 1606284
[No Abstract] [Full Text] [Related]
9. Drug counterfeiting burden remains a guess, experts say.
Traynor K
Am J Health Syst Pharm; 2009 Jul; 66(14):1246-8. PubMed ID: 19574593
[No Abstract] [Full Text] [Related]
10. [Counterfeit and fake drugs: medications that kill].
Ambroise-Thomas P
Med Trop (Mars); 2010 Jun; 70(3):213-4. PubMed ID: 20734583
[No Abstract] [Full Text] [Related]
11. Counterfeit and substandard drugs in India may be smaller problem than claimed, say government findings.
Travasso C
BMJ; 2014 Jan; 348():g60. PubMed ID: 25489932
[No Abstract] [Full Text] [Related]
12. Double standards in GMP deduplication row.
Hodgson J; Fox JL
Nat Biotechnol; 1996 Dec; 14(13):1647-8. PubMed ID: 9634839
[No Abstract] [Full Text] [Related]
13. Remarks delivered at the Food and Drug Law Institute's 48th Annual Conference.
Enzi MB
Food Drug Law J; 2005; 60(2):103-6. PubMed ID: 16097090
[No Abstract] [Full Text] [Related]
14. Inspections: the international regulatory view.
Turner JL
PDA J Pharm Sci Technol; 1994; 48(4):180-1. PubMed ID: 7804815
[No Abstract] [Full Text] [Related]
15. [Drug counterfeiting and counter measures. Study by the Hungarian National Alliance Against Drug Counterfeiting].
Psychiatr Hung; 2009; 24(3):205-14. PubMed ID: 20017282
[No Abstract] [Full Text] [Related]
16. Substandard and counterfeit medicines.
Rassool GH
J Adv Nurs; 2004 May; 46(3):338-9. PubMed ID: 15119344
[No Abstract] [Full Text] [Related]
17. [The drug trade between European countries and developing countries].
Bruneton C; Naboulet P; van der Heide B; Rey JL
Med Trop (Mars); 1997; 57(4):375-9. PubMed ID: 9612781
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceuticals: drug importation--2005. End of Year Issue Brief.
Varma P; Seay M
Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708457
[No Abstract] [Full Text] [Related]
19. Unfair competition under the TRIPS agreement: protection of data submitted for the registration of pharmaceuticals.
Correa CM
Chic J Int Law; 2002; 3(1):69-85. PubMed ID: 15709300
[No Abstract] [Full Text] [Related]
20. Global perspective on specifications for biotechnology products--perspective from Japan.
Hayakawa T
Dev Biol Stand; 1997; 91():15-23. PubMed ID: 9413678
[No Abstract] [Full Text] [Related]
[Next] [New Search]
